Professor Gareth Griffiths

Professor Gareth Griffiths

Director Clinical Trials Unit

Research interests

  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials Unit.  He works with clinicians, research groups and other scientists in the development of important clinical trials and other well-designed studies that aim to improve the treatment of a range of cancers and other diseases, and early diagnosis of cancer.
  • His works spans the different phases of clinical trials, from small dose finding and safety studies involving a handful of patients to larger trials of hundreds of patients looking at whether the treatments are better than the current standard treatments.  His early diagnosis studies include thousands of patients looking at new ways to detect cancer early.  Ultimately, these studies could help change the way that patients are treated for the better, by creating the evidence so as the new treatments becomes the standard of care for future patients treated in the NHS.
  • Phase I-III clinical trials

More research

Connect with Gareth

Research

Research groups

Research interests

  • Gareth Griffiths is Professor of Clinical Trials and directs our Southampton Clinical Trials Unit.  He works with clinicians, research groups and other scientists in the development of important clinical trials and other well-designed studies that aim to improve the treatment of a range of cancers and other diseases, and early diagnosis of cancer.
  • His works spans the different phases of clinical trials, from small dose finding and safety studies involving a handful of patients to larger trials of hundreds of patients looking at whether the treatments are better than the current standard treatments.  His early diagnosis studies include thousands of patients looking at new ways to detect cancer early.  Ultimately, these studies could help change the way that patients are treated for the better, by creating the evidence so as the new treatments becomes the standard of care for future patients treated in the NHS.
  • Phase I-III clinical trials
  • Early Diagnosis studies
  • Trial Methodology

Research projects

Active projects

Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: F. Hoffmann-La Roche Ltd
Researchers:
Sponsor: BioNTech
Researchers:
Sponsor: Cancer Research UK
Researchers:
Researchers:
Researchers:
Researchers:
Researchers:

Completed projects

Researchers:
Sponsor: Ludwig Institute for Cancer Research Ltd
Researchers:
Sponsor: International Extranodal Lymphoma Study Group
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: ClearNote Health
Researchers:
Sponsor: Blood Cancer UK
Researchers:
Sponsor: Astex Pharmaceuticals, Inc.
Researchers:
Sponsor: Cancer Research UK
Researchers:
Researchers:
Researchers:
Researchers: